Jesper Hallas

Jesper Hallas is Professor of Clinical Pharmacology at the University of Southern Denmark's Department of Public Health, where he leads pharmacoepidemiological research. He established the Odense University Pharmacoepidemiologic Database (OPED) in 1990, enabling comprehensive prescription drug tracking for 1.2 million Southern Danes.

• Academic credentials: MD (University of Copenhagen, 1984)
• Key collaborations: Odense University Hospital clinical units, General Practice Research Unit, and International Society for Pharmacoepidemiology (Chair, 2012-2015)

His research focuses on drug safety, adverse drug reactions, and prescription pattern analysis. Current projects examine cardiovascular drug effects (statins, beta-blockers), drug repositioning for abdominal aortic aneurysms, and academic movement break interventions (PauseNørd study).

Recent publications highlight 2025 findings on:

• Rimegepant adoption patterns
• Statin dose-response in aortic aneurysms
• Preoperative dental screening effectiveness
• Antithrombotic drug safety
• NSAID cardiovascular risks
• Vaccine effectiveness monitoring

His work employs self-controlled designs, sequence symmetry analysis, and registry-based cohort studies, with particular emphasis on Danish health registries for real-world evidence generation.

Scientific recognition includes:

• Ridder af Dannebrog (2018) - Royal Danish honor
• Faculty Teaching Prize (2010)

Current affiliations involve active leadership in pharmacoepidemiological research networks and advisory roles in major studies like the DANCAVAS trial and BRAHMS observational study.